OBJECTIVE: The objective of this study was to examine the prevalence and correlates of self-reported attention deficit disorder (ADD)/ADHD in Canadian adults. METHOD: Prevalence of self-reported ADD/ADHD was examined in a large national sample of Canadians ( n = 16,957). Demographic variables, lifetime, and current psychiatric comorbidities were then compared in a group of adults with self-reported ADD/ADHD ( n = 488) and an age- and gender-matched control group ( n = 488). RESULTS: The prevalence of self-reported ADD/ADHD was 2.9%. Significantly higher lifetime and current prevalence rates of major depressive disorder, bipolar I and II disorders, generalized anxiety disorder, and substance use disorders were observed in the ADD/ADHD group compared with the control group. Within the ADD/ADHD group, lifetime and 12-month prevalence rates of major depressive disorder and generalized anxiety disorder were significantly higher in women, whereas lifetime and current rates of some substance use disorders were significantly higher in men. CONCLUSION: In a national sample of Canadian adults, self-reported ADD/ADHD was associated with significant psychiatric comorbidity. Gender differences were also noted.
OBJECTIVE: The objective of this study was to examine the prevalence and correlates of self-reported attention deficit disorder (ADD)/ADHD in Canadian adults. METHOD: Prevalence of self-reported ADD/ADHD was examined in a large national sample of Canadians ( n = 16,957). Demographic variables, lifetime, and current psychiatric comorbidities were then compared in a group of adults with self-reported ADD/ADHD ( n = 488) and an age- and gender-matched control group ( n = 488). RESULTS: The prevalence of self-reported ADD/ADHD was 2.9%. Significantly higher lifetime and current prevalence rates of major depressive disorder, bipolar I and II disorders, generalized anxiety disorder, and substance use disorders were observed in the ADD/ADHD group compared with the control group. Within the ADD/ADHD group, lifetime and 12-month prevalence rates of major depressive disorder and generalized anxiety disorder were significantly higher in women, whereas lifetime and current rates of some substance use disorders were significantly higher in men. CONCLUSION: In a national sample of Canadian adults, self-reported ADD/ADHD was associated with significant psychiatric comorbidity. Gender differences were also noted.
Authors: Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Robert G Voigt; Jill M Killian; Amy L Weaver; Slavica K Katusic Journal: J Atten Disord Date: 2016-11-18 Impact factor: 3.256
Authors: Giancarlo Giupponi; Marco Innamorati; Elena Rogante; Salvatore Sarubbi; Denise Erbuto; Ignazio Maniscalco; Livia Sanna; Andreas Conca; David Lester; Maurizio Pompili Journal: Int J Environ Res Public Health Date: 2020-04-21 Impact factor: 3.390
Authors: Sarah Kittel-Schneider; Sarah Wolff; Kristin Queiser; Leonie Wessendorf; Anna Maria Meier; Moritz Verdenhalven; Nathalie Brunkhorst-Kanaan; Oliver Grimm; Rhiannon McNeill; Sascha Grabow; Christoph Reimertz; Christoph Nau; Michelle Klos; Andreas Reif Journal: J Clin Med Date: 2019-10-08 Impact factor: 4.241
Authors: Alessandro Pallucchini; Marco Carli; Marco Scarselli; Icro Maremmani; Giulio Perugi Journal: Int J Environ Res Public Health Date: 2021-01-21 Impact factor: 3.390
Authors: Rachael Morkem; Kenneth Handelman; John A Queenan; Richard Birtwhistle; David Barber Journal: BMC Med Inform Decis Mak Date: 2020-07-20 Impact factor: 2.796
Authors: Jesse Elliott; Amy Johnston; Don Husereau; Shannon E Kelly; Caroline Eagles; Alice Charach; Shu-Ching Hsieh; Zemin Bai; Alomgir Hossain; Becky Skidmore; Eva Tsakonas; Dagmara Chojecki; Muhammad Mamdani; George A Wells Journal: PLoS One Date: 2020-10-21 Impact factor: 3.240